Research Article

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

Figure 5

(a, b) Difference in the proportion of 22 TIICs in LUAD samples and nontumor samples.
(a)
(b)